According to WiseGuyReports, the β-Nicotinamide Mononucleotide Market is expected to rise from USD 1.2 billion in 2025 to USD 5.0 billion by 2035, reflecting a compound annual growth rate (CAGR) of 15.5% over the 2026–2035 forecast period. The market's 2024 valuation stood at USD 1,000 million. Growing consumer interest in healthy aging, expanding nutraceutical applications...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek